Company profile for ALK

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ALK is a global allergy solutions company, with a wide range of allergy treatments, products and services that meet the unique needs of allergy sufferers, their families and healthcare professionals. At ALK, we have a proud heritage of pioneer research dating all the way back to our founders nearly 100 years ago. Back then, research was small-scale, the evidence for allergy immunotherapy was limited and medical science was sti...
ALK is a global allergy solutions company, with a wide range of allergy treatments, products and services that meet the unique needs of allergy sufferers, their families and healthcare professionals. At ALK, we have a proud heritage of pioneer research dating all the way back to our founders nearly 100 years ago. Back then, research was small-scale, the evidence for allergy immunotherapy was limited and medical science was still in its infancy. Over the decades, things have changed immensely, and ALK has been responsible for many of the innovations we now take for granted in our understanding of allergy and its treatment.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
Bøge Allé 6-8 DK-2970 Hørsholm
Telephone
Telephone
(+45) 4574 7576
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3197134/0/en/ALK-appoints-Edward-Jordan-as-new-EVP-and-head-of-Commercial-Operations-North-America.html

GLOBENEWSWIRE
01 Dec 2025
ALK Upgrades Its Full-Year Outlook
ALK Upgrades Its Full-Year Outlook

12 Nov 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/11/12/3186538/0/en/ALK-upgrades-its-full-year-outlook.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/12/3186544/0/en/Nine-month-interim-report-Q3-2025-unaudited.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3182861/0/en/Invitation-to-the-presentation-of-ALK-s-first-nine-months-Q3-2025-results-on-Thursday-13-November-2025.html

GLOBENEWSWIRE
06 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-20/new-needle-free-treatment-option-for-life-threatening-anaphylaxis-eurneffy-now-available-in-the-u

PHARMIWEB
20 Oct 2025

https://www.globenewswire.com/news-release/2025/09/17/3151399/0/en/ALK-and-GenSci-partner-to-expand-the-AIT-market-in-China.html

GLOBENEWSWIRE
17 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty